Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Couce, M.
Right arrow Articles by Butler, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Couce, M.
Right arrow Articles by Butler, P. C.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 45:1094-1101, 1996
© 1996 by the American Diabetes Association, Inc.

Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction

ABSTRACT

Islet amyloid derived from islet amyloid polypeptide (IAPP) is a well-recognized feature of type II diabetes. However, the mechanism of islet amyloidogenesis is unknown. In vitro studies suggest that amino acid residues 20-29 in human, but not mouse, IAPP confer amyloidogenicity consistent with the absence of spontaneous islet amyloidosis in mice. Several clinical and in vitro studies suggest that increased synthetic rates of IAPP predispose to IAPP-amyloidosis. In the present study, we sought to test the hypothesis that pharmacological induction of insulin resistance in a mouse transgenic (TG) for human IAPP would induce islet amyloid and beta-cell dysfunction. TG and non-transgenic (N-TG) control mice were treated with both rat growth hormone (12 micrograms/day) and dexamethasone (0.24 mg/day) (dex/GH) or received no treatment for 4 weeks, after which animals were killed to examine islet morphology. Treatment with dex/GH caused hyperglycemia (7.3 +/- 0.4 vs. 5.2 +/- 0.1 mmol/l, TG vs. N-TG, P < 0.001) associated with a decreased plasma insulin concentration (595 +/- 51 vs. 996 +/- 100 pmol/l, TG vs. N-TG, P < 0.05) in TG versus control mice. Islet amyloid was induced in treated TG mice but not in control mice. Islet amyloid was identified in both intra- and extracellular deposits, the former being associated with evidence of beta-cell degeneration. We conclude that dex/GH treatment in mice TG for human IAPP induces IAPP-derived islet amyloid, hyperglycemia, and islet dysfunction. The present model recapitulates the islet morphology and phenotype of type II diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
S. Bonner-Weir and T. D. O'Brien
Islets in Type 2 Diabetes: In Honor of Dr. Robert C. Turner
Diabetes, November 1, 2008; 57(11): 2899 - 2904.
[Full Text] [PDF]

Home page
 DiabetesHome page
W. P.S. Wong, D. W. Scott, C.-L. Chuang, S. Zhang, H. Liu, A. Ferreira, E. L. Saafi, Y. S. Choong, and G. J.S. Cooper
Spontaneous Diabetes in Hemizygous Human Amylin Transgenic Mice That Developed Neither Islet Amyloid nor Peripheral Insulin Resistance
Diabetes, October 1, 2008; 57(10): 2737 - 2744.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
L. Haataja, T. Gurlo, C. J. Huang, and P. C. Butler
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Endocr. Rev., May 1, 2008; 29(3): 303 - 316.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Zhang, H. Liu, H. Yu, and G. J.S. Cooper
Fas-Associated Death Receptor Signaling Evoked by Human Amylin in Islet {beta}-Cells
Diabetes, February 1, 2008; 57(2): 348 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C.-j. Huang, L. Haataja, T. Gurlo, A. E. Butler, X. Wu, W. C. Soeller, and P. C. Butler
Induction of endoplasmic reticulum stress-induced -cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1656 - E1662.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C.-Y. Lin, T. Gurlo, R. Kayed, A. E. Butler, L. Haataja, C. G. Glabe, and P. C. Butler
Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP-Induced {beta}-Cell Apoptosis in h-IAPP Transgenic Mice
Diabetes, May 1, 2007; 56(5): 1324 - 1332.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Marzban, C. J. Rhodes, D. F. Steiner, L. Haataja, P. A. Halban, and C. B. Verchere
Impaired NH2-Terminal Processing of Human Proislet Amyloid Polypeptide by the Prohormone Convertase PC2 Leads to Amyloid Formation and Cell Death.
Diabetes, August 1, 2006; 55(8): 2192 - 2201.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. V. Matveyenko and P. C. Butler
{beta}-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes.
Diabetes, July 1, 2006; 55(7): 2106 - 2114.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Marzban, G. Soukhatcheva, and C. B. Verchere
Role of Carboxypeptidase E in Processing of Pro-Islet Amyloid Polypeptide in {beta}-Cells
Endocrinology, April 1, 2005; 146(4): 1808 - 1817.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. L. Hull, G. T. Westermark, P. Westermark, and S. E. Kahn
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3629 - 3643.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. E. Butler, J. Jang, T. Gurlo, M. D. Carty, W. C. Soeller, and P. C. Butler
Diabetes Due to a Progressive Defect in {beta}-Cell Mass in Rats Transgenic for Human Islet Amyloid Polypeptide (HIP Rat): A New Model for Type 2 Diabetes
Diabetes, June 1, 2004; 53(6): 1509 - 1516.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Janson, T. Laedtke, J. E. Parisi, P. O'Brien, R. C. Petersen, and P. C. Butler
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Diabetes, February 1, 2004; 53(2): 474 - 481.
[Abstract] [Full Text]

Home page
 DiabetesHome page
A. E. Butler, J. Janson, W. C. Soeller, and P. C. Butler
Increased {beta}-Cell Apoptosis Prevents Adaptive Increase in {beta}-Cell Mass in Mouse Model of Type 2 Diabetes: Evidence for Role of Islet Amyloid Formation Rather Than Direct Action of Amyloid
Diabetes, September 1, 2003; 52(9): 2304 - 2314.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. G. Bennett, F. G. Hamel, and W. C. Duckworth
An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures
Diabetes, September 1, 2003; 52(9): 2315 - 2320.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. A. Ritzel and P. C. Butler
Replication Increases {beta}-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis
Diabetes, July 1, 2003; 52(7): 1701 - 1708.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. Wang, R. L. Hull, J. Vidal, M. Cnop, and S. E. Kahn
Islet Amyloid Develops Diffusely Throughout the Pancreas Before Becoming Severe and Replacing Endocrine Cells
Diabetes, November 1, 2001; 50(11): 2514 - 2520.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J.-M. Ye, M. Lim-Fraser, G. J. Cooney, G. J. S. Cooper, M. A. Iglesias, D. G. Watson, B. Choong, and E. W. Kraegen
Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance
Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E562 - E569.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Hoenig, G. Hall, D. Ferguson, K. Jordan, M. Henson, K. Johnson, and T. O'Brien
A Feline Model of Experimentally Induced Islet Amyloidosis
Am. J. Pathol., December 1, 2000; 157(6): 2143 - 2150.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H. J. Hiddinga and N. L. Eberhardt
Intracellular Amyloidogenesis by Human Islet Amyloid Polypeptide Induces Apoptosis in COS-1 Cells
Am. J. Pathol., April 1, 1999; 154(4): 1077 - 1088.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.